Wockhardt Limited

₹2,006As of Sun 8 Nov 2026, 12:00 UTC
NSE:WOCKPHARMAHealthcare
Country India
PE (Fwd) •••
TSR 10Y CAGR 9.72%
Div yield —
ROE 7.81%
Drug Manufacturers (Specialty & Generic)
Beta (5Y) 1.04
PE TTM 78.54
TSR TTM 56.56%
Mkt cap ₹326.0B
ROIC 7.64%
SE Grade™
Value
Quality
Moat
Consensus
Reference
₹1,973
(1.68%)
(74.54%)
Hold 4|4|3|5|12
3Q26
4Q26
1Q27
2Q27
Earnings per share₹
40.78
41.40
45.79
46.93
30.46%
25.99%
27.75%
23.19%
Revenue₹B
19.15
20.22
21.26
22.43
9.98%
16.30%
18.11%
21.25%
Peers (US$3.379B)
Cap (US$)
PE
4.390B
32.67x
Capital
TTM
5Y
10Y
Leveragex
2.872
0.071
0.061
EBIT/Intx
0.235
0.324
0.304
Own earn%
(78.92)
(50.14)
(64.41)
Sh yield%
29.66
23.08
24.63
Owners
Insiders/Inst%
13.46
81.51
Short interest%
2.26
SBC / revenue%
2.21
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
3
Op margin range%
13–21
$1 testx
—
Incr. ROIC%
27